TIDMFDBK
Feedback PLC
11 October 2021
RNS REACH
Feedback plc
Feedback signs MOU with Quest Teleradiology to progress Bleepa
commercial international opportunities
-- Quest Teleradiology is an Indian based diagnostic and
tele-reporting teleradiology service company with healthcare
customers across India, the UK and Africa
-- Bleepa enables image transfer from Quest customer sites to
Quest Radiologists for reporting and presents the subsequent
reports back to requesting clinicians
-- Bleepa additionally enables two way dialogue between the
referring clinician and reporting Radiologist, enhancing the
clinical value of the teleradiology service
London, 11 October 2021: Feedback plc (AIM: FDBK, "Feedback" or
the "Company"), the specialist clinical communication company,
announces it has signed a Memorandum of Understanding with Quest
Teleradiology Solutions ("Quest") to develop strategic
opportunities for Bleepa, its flagship clinical communications
platform, in the large and growing Indian healthcare market, the UK
and internationally. Bleepa offers the opportunity to expand
Quest's existing teleradiology service by enabling direct case
discussion between requesting clinicians and reporting Radiologists
alongside the traditional teleradiology reporting model.
Quest is one of India's emerging teleradiology organisations
with customers across India, the UK and throughout Africa. Under
the collaboration, Quest will be able to offer a more integrated
reporting service to hospitals and trial Bleepa's technology with a
number of its international customers to understand the added value
that case discussion brings to traditional outsourced reporting
models. In traditional outsourced reporting models, it is often
difficult for a requesting clinician to discuss the case with the
Radiologist who reports it, usually having to rely on email or
switchboard coordinated calls in order to get answers to questions
about the report. Similarly, it is difficult for the reporting
Radiologist to get additional clinical information beyond what is
contained in the imaging request, but which could enhance the
quality of their report. This leads to customer dissatisfaction
with many outsourced reporting services.
Quest is one of the first outsourced reporting services to
assess the benefits of enhanced communication to their service
offering. Both companies believe that case-based discussion will
help the outsourced reporting service to feel like a fully embedded
clinical service at customer sites, enhancing the value to the
customer and helping to improve the quality of the reports
generated by improving Radiologist access to clinical information
at the time of reporting.
Combining Bleepa's mobile-based technology with Quest's
teleradiology expertise, will create a blueprint for how outsourced
services should be integrated into core clinical services using the
Bleepa platform and will open growth opportunities for both
companies in multiple markets.
Dr Karthik Gopal, CEO of Quest, commented : "Bleepa is an
extremely exciting innovation that will mean that we will be able
to offer Hospitals highly efficient access to our reporting
resources as well as a service to our own customers which is
quicker and more efficient than ever before."
Dr Tom Oakley, CEO of Feedback, added: "This collaboration is
expected to put Bleepa in the hands of more clinicians and key
stakeholders and we are delighted to have been chosen to enhance
Quest's product offering. Quest brings significant expertise as
well as a strong network of contacts, customers and opportunities
through which we aim to introduce Bleepa. We look forward to
working with Quest and opening up new markets across all
international territories."
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Panmure Gordon (UK) Limited (NOMAD
and Broker)
Emma Earl/Freddy Crossley (Corporate
Finance)
Rupert Dearden (Corporate Broking) +44 (0)20 7886 2500
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236 or
Johnson 07884 664 686
Notes to Editors
Feedback plc (AIM: FDBK) is a pioneer of regulated clinical
communication products. Its core product, Bleepa, is a
revolutionary medical imaging communications app, providing an
easy-to-use, high quality tool to enable remote and secure
communications between front-line clinicians and teams.
Importantly, it is the only CE marked medical imaging
communications platform on the NHSx clinical communications tools
framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS") based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care providers. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of clinical
review.
About Quest Teleradiology -
http://www.questteleradiology.com/
Quest Teleradiology Solutions is a Bangalore based company that
provides complete radiology services extending from diagnostic
business development to Tele reporting. Quest Teleradiology is a
team of experienced Doctors, operational managers and IT experts
committed to improving healthcare through technology, committed to
make healthcare cost effective and to bridge the gap in service
delivery through technology. Currently Quest services clients from
Asia, Africa and Europe continents and is focussed to leverage
technology to take healthcare to the needy at the right time and at
affordable range, saving resources.
About RNS Reach announcements
This is an RNS Reach announcement. RNS Reach is an investor
communication service aimed at assisting listed and unlisted
(including AIM quoted) companies to distribute media only /
non-regulatory news releases into the public domain. Information
required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an
RNS regulatory announcement and not on RNS Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUWUNRABURRAA
(END) Dow Jones Newswires
October 11, 2021 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Feedback (LSE:FDBK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
